The Week In Weed: June 26, 2020

SS
Seyfarth Shaw LLP

Contributor

With more than 900 lawyers across 18 offices, Seyfarth Shaw LLP provides advisory, litigation, and transactional legal services to clients worldwide. Our high-caliber legal representation and advanced delivery capabilities allow us to take on our clients’ unique challenges and opportunities-no matter the scale or complexity. Whether navigating complex litigation, negotiating transformational deals, or advising on cross-border projects, our attorneys achieve exceptional legal outcomes. Our drive for excellence leads us to seek out better ways to work with our clients and each other. We have been first-to-market on many legal service delivery innovations-and we continue to break new ground with our clients every day. This long history of excellence and innovation has created a culture with a sense of purpose and belonging for all. In turn, our culture drives our commitment to the growth of our clients, the diversity of our people, and the resilience of our workforce.
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.
United States Cannabis & Hemp

Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.

We begin with the claim that the Justice Department brought antitrust actions against cannabis companies due to Attorney General Bill Barr's antipathy towards the industry. The state of New Jersey is contemplating decriminalization, and Montana may have cannabis on the ballot. The city of Denver gets into the R&D business. Should the FDA issue a CBD rule quickly? Some consumer groups say no. Medical marijuana is now permitted to those on parole or probation. And finally, we have an update on the Oklahoma fake email story!

antitrust and marijuana

DOJ attorney John Elias testified this week that the department was improperly investigating cannabis companies for antitrust violations. Video of the hearing is available here. Written testimony is available here. The DOJ's Office of Professional Responsibility looked into the matter earlier this month and found no evidence of wrongdoing. The memorandum is available here (subscription required).

new jersey

New Jersey is considering decriminalizing marijuana possession. The state Assembly recently passed a bill substituting a fine for arrest for possession of up to two ounces of marijuana. The bill now moves to the state Senate, where opinions against the legislation have recently shifted.

montana

New Approach Montana submitted over 130,000 signatures in support of two ballot initiatives to legalize and regulate adult-use cannabis in the state. This is far above the number of signatures needed to put the measures before the voters, so it seems likely that they will make the November ballot.

research & development

The city of Denver awarded its first license for medical marijuana R&D. MedPharm hopes to start work on its first project, studying marijuana's effect on Alzheimer's and dementia, by the end of 2020.

cbd rule

For years, the hemp and CBD industries have been waiting impatiently for the Food and Drug Administration to issue regulations on cannabidiol. Now several consumer groups are suggesting they need to wait a bit longer. The groups sent a joint letter to members of Congress, urging them not to push the FDA to issue regulations, as their attention has been diverted due to the pandemic.

pennsylvania

The Pennsylvania Supreme Court struck down a county law forbidding the use of medical marijuana by those on probation or parole. The unanimous decision applies throughout the state.

and finally

Regular readers of this column will doubtless recall that the general counsel of the Oklahoma Department of Health sent herself threatening emails, which she claimed were from cannabis advocates. She's now been suspended from practicing law (subscriptoin required) for one year. You just can't make this stuff up.

Stay safe and be well everyone - we'll see you next week!

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More